Medical supply and logistics company Owens & Minor (NYSE:OMI) will be announcing earnings results this Monday before market ...

Owens & Minor Inc (OMI) reports a 3.3% revenue increase while focusing on strategic divestitures and overcoming supply chain ...

Owens & Minor is focused on paying down debt and rethinking how it builds momentum in its “pure-play” Patient Direct business ...

Citigroup analyst Daniel Grosslight maintained Owens & Minor with a Buy and lowered the price target from $11 to $7. Baird ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

An announcement from Owens & Minor ( ($OMI) ) is now available. On August 11, 2025, Owens & Minor reported its second-quarter financial results, ...

Coliseum Capital, a ten-percent owner of Owens & Minor INC/VA/ (NYSE:OMI), has recently purchased shares of the company worth approximately $8.1 million. These purchases, executed between August 12 ...

Earlier in the day, Owens & Minor reported second-quarter adjusted earnings of $0.26 per share, missing the Street estimate by $0.02 per share. Its quarterly revenue rose 3.3% to $681.9M.

Owens & Minor's canceled Rotech deal eases financial risks. Click to read a full investment analysis of OMI stock and why its ...

Owens & Minor says it is in the final stages of selling its Products & Healthcare Services segment, says CEO Ed Pesicka.

On Monday, Owens & Minor Inc. (NYSE:OMI) reported adjusted earnings for the second quarter that missed analyst projections as ...

The company’s adjusted EBITDA from continuing operations increased to $96.6 million in the second quarter, compared to $91.1 million in the prior-year period. Owens & Minor has classified its Products ...